Bruce Langoulant - Articles and news items

Novartis logo

Novartis vaccine Bexsero® approved in Australia to help protect against MenB disease

Industry news, News / 15 August 2013 / Novartis

The Australian Therapeutic Goods Administration (TGA) has added Bexsero® to the Australian Register of Therapeutic Goods (ARTG)…

Novartis logo

Novartis receives positive CHMP opinion for Bexsero®

Industry news, News / 16 November 2012 / Novartis

The CHMP of the EMA has adopted a positive opinion for Bexsero for use in individuals from 2 months of age and older…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...